Case 10-2011: A woman with fever, confusion, liver failure, anemia, and thrombocytopenia

New England Journal of Medicine

Volumn 364, Issue 13, 2011, Pages 1259-1270

  Tierney Jr , Lawrence M ^a,b   Thabet, Ashraf ^c   Nishino, Ha ^d  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMFEBUTAMONE; AMOXICILLIN; AMPHOTERICIN B LIPID COMPLEX; ANTACID AGENT; CD163 ANTIGEN; CD68 ANTIGEN; CEFEPIME; CEFTRIAXONE; D DIMER; DEXAMETHASONE; DOXYCYCLINE; ETOPOSIDE; FLUOXETINE; FRESH FROZEN PLASMA; GLUCOCORTICOID; HALOPERIDOL; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; LACTULOSE; OMEPRAZOLE; PANTOPRAZOLE; PEGINTERFERON ALPHA2B; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN; RIFAXIMIN; VANCOMYCIN; VITAMIN K GROUP; VORICONAZOLE; FERRITIN;

ABDOMINAL TENDERNESS; ADULT; AGITATION; ANEMIA; ANXIETY DISORDER; ARTICLE; BONE MARROW BIOPSY; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; CONFUSION; CYTOKINE STORM; CYTOPENIA; DEPRESSION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISORIENTATION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECCHYMOSIS; ERYTHROCYTE TRANSFUSION; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; FLAPPING TREMOR; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; IMMUNE DEFICIENCY; INFECTION; JAUNDICE; LIVER CIRRHOSIS; LIVER FAILURE; LUMBAR PUNCTURE; LUNG EDEMA; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC DISEASE; NEUTROPENIA; PRIORITY JOURNAL; RESTLESSNESS; SEROTONIN SYNDROME; SLURRED SPEECH; SPLENOMEGALY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; URINALYSIS; ABDOMINAL RADIOGRAPHY; BLOOD; BONE MARROW; BRAIN; CLINICAL OBSERVATION; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSIS; FATALITY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY;

ANEMIA; BONE MARROW; BRAIN; CONFUSION; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; FERRITINS; FEVER; HEPATITIS C, CHRONIC; HUMANS; INFECTION; LIVER FAILURE; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MIDDLE AGED; RADIOGRAPHY, ABDOMINAL; THROMBOCYTOPENIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79953178585     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1013924     Document Type: Article

References (20)

1. Poynard T, Imbert-Bismut F, Munteanu M, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004;3:8-19.
2. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002;36:1439-45. (Pubitemid 35403535)
3. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease: review of extrahepatic manifestations. Ann Intern Med 1995;123:615-20.
4. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010;362:1071-81.
5. Johnson RJ, Gretch DR, Couser WG, et al. Hepatitis C virus-associated glomerulonephritis: effect of alpha-interferon therapy. Kidney Int 1994;46:1700-4. (Pubitemid 24370487)
6. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007;297:2010-7. (Pubitemid 46740353)
7. Ramos-Casals M, Muñoz S, Medina F, et al. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (the HISPAMEC Registry). J Rheumatol 2009; 36:1442-8.
8. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39:1147-71. [Erratum, Hepatology 2004;40:269.]
9. Zeuzem S. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med 2004;140:370-81.
10. Case Records of the Massachusetts General Hospital (Case 12-1963). N Engl J Med 1963;258:378-85.
11. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335-74.
12. Warner JL, Najarian RM, Tierney LM Jr. Uses and misuses of thresholds in diagnostic decision making. Acad Med 2010;85:556-63.
13. Favara BE. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol 1992;9:63-74.
14. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000;6:601-8. (Pubitemid 32110502)
15. Dufourcq-Lagelouse R, Pastural E, Barrat FJ, et al. Genetic basis of hemophagocytic lymphohistiocytosis syndrome. Int J Mol Med 1999;4:127-33.
16. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991;18:29-33.
17. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein- Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997;100:1969-79. (Pubitemid 27459350)
18. McClain KL. Hemophagocytic lymphohistiocytosis. In: Berliner N, Landaw, SA, eds. UpToDate. Waltham, MA: UpToDate, 2011.
19. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009:127-31.
20. Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005:82-8.